Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
about
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the BrainVascular dysfunction as a target for adjuvant therapy in cerebral malariaExperimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierNeuroimmunological blood brain barrier opening in experimental cerebral malariaPharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malariaThe Malaria-High Blood Pressure Hypothesis.Imaging Plasmodium immunobiology in the liver, brain, and lung.Angiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia.Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malariaSystemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment.Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkersHeme-Mediated Induction of CXCL10 and Depletion of CD34+ Progenitor Cells Is Toll-Like Receptor 4 DependentPathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.Dysregulation of the haem-haemopexin axis is associated with severe malaria in a case-control study of Ugandan children.VEGF and LPS synergistically silence inflammatory response to Plasmodium berghei infection and protect against cerebral malariaA clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria.Early prediction of cerebral malaria by (1)H NMR based metabolomicsHost Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.Biomarkers of endothelial activation/dysfunction in infectious diseases.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.Immunobiology of Plasmodium in liver and brain.The mechanistic, diagnostic and prognostic utility of biomarkers in severe malaria.Pathogenesis of cerebral malaria--inflammation and cytoadherence.The immunological balance between host and parasite in malaria.Therapeutic targeting of the angiopoietin-TIE pathway.Differential regulation of angiopoietin 1 and angiopoietin 2 during dengue virus infection of human umbilical vein endothelial cells: implications for endothelial hyperpermeability.Synthetic oleanane triterpenoids enhance blood brain barrier integrity and improve survival in experimental cerebral malaria.Endothelial Activation: The Ang/Tie Axis in Sepsis.
P2860
Q26778543-A22C85BF-3E5E-4CC0-9AFB-05E3A4A4CA37Q27025436-0B30C0D4-4414-4942-8477-3F0E16FD89A0Q27322655-519D77DA-DE7A-4412-A331-D69BFF0AAF78Q27341951-DD6471BF-FA3A-4588-8443-5F640BEF93E4Q28486022-06983A35-5F1E-4B9E-873C-DC25FB694E18Q30251413-2589C997-EE5E-451C-8CC5-7FCAA87F5D95Q30561036-90483C2A-CAE2-4A91-8BA0-7930AC44958FQ33417944-DCBB7631-2120-41E2-8164-56920A54BAE8Q33419656-CC12E5F5-C547-480B-AC75-FAC288539927Q33775828-106ADDBD-FAE0-475C-9281-261C36600D25Q34765904-E52A8817-92C0-40A7-9642-06B3ECB01B59Q35837528-17ED24A2-7BE7-44AC-BB96-3C4A2DB25985Q36209383-A48B4E75-656E-4E3F-8F2B-2777948F9FEDQ36393876-BE82D018-0D01-44F6-AF7C-963740257078Q36504376-E3F979F7-5737-476F-8DE9-EBCC43A7B3BAQ36604263-360D3709-9C36-46A0-ACAE-0D61D69A2197Q36790143-A9C5F4B4-5FBF-4D09-8C5F-35569D145D44Q37305512-F647CF6B-E473-4551-B3EC-9014B9669DA2Q37466271-0E02262A-3579-4FFC-B554-114D69B46BF7Q37532357-E13A0191-D794-49F2-BCFA-93316924DC5DQ37713182-EBCC9488-6244-46C2-9590-45D78556910BQ37713193-8ED49360-FDDE-48D8-8E68-8530F86DCEABQ38103059-264BD47B-59F6-4F57-B9BF-CA3500F53077Q38111808-93420731-510D-4652-8B2C-B39F088C2790Q38239690-EC0871AA-FC73-4363-A5A1-038CD32EB077Q38666558-34B56DC7-ECD6-4EDB-90FD-FF47B5CCEDFCQ39321127-4CBAF22A-A98A-47C3-A36A-71DA48C605B1Q40236472-5D34907C-C853-42FA-8CAE-44323989EDF9Q47093575-71B3FE77-1D93-46E5-BD87-9D0E57511ABBQ54217602-CE1D1568-4423-4339-B335-A6482E0B3A3E
P2860
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@ast
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@en
type
label
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@ast
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@en
prefLabel
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@ast
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@en
P2093
P2860
P50
P921
P356
P1433
P1476
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.
@en
P2093
Anna J Blackstock
Avinash C Nagpal
Nana O Wilson
Naomi W Lucchi
Neeru Singh
Pradeep K Joel
Vidhan Jain
P2860
P2888
P356
10.1186/1475-2875-10-383
P577
2011-12-23T00:00:00Z
P5875
P6179
1039882937